Clinical Trial: DiEtary Mimicry by Glucocorticoid Modulation Evaluation in ER+ Metastatic Breast Cancer Treatment: Efficacy and Response (DEMETER Trial)

U.S., Aug. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07786051) titled 'DiEtary Mimicry by Glucocorticoid Modulation Evaluation in ER+ Metastatic Breast Cancer Treatment: Efficacy and Response (DEMETER Trial)' on Aug. 21.

Brief Summary: This is a single centre, open label, phase II clinical study consisting of two parts, each consisting of a different dose of the same intervention to investigate the efficacy of dexamethasone as an adjunct to endocrine therapy in the treatment of ER+ HER2- metastatic breast cancer after progression on the same endocrine therapy.

Study Start Date: Nov. 01, 2026

Study Type: INTERVENTIONAL

Condition: Breast Cancer

Intervention: DRUG: Dexamethasone (Oral)

Commercially...